3 ms·

Does Betteridge’s law of headlines apply here?

• eru 2y ago
  [flagged]
• pindab0ter 2y ago
  Reading the article, it doesn't seem so. The drug looks promising, even though it will probably not work in all cases.
  • kettleballroll 2y ago
    I disagree. This article is typical embellishment from the university that produced the research. The reality is that they're likely pre-trial stage. Even if they make it through all stages of clinical trials (historically, chances of a drug candidate doing that are 2-5%), that usually takes the better part of a decade. So the answer is "no, we're very far from curing it".
    • hagbard_c 2y ago
      They're at phase 2a trial stage, study start was at 2024-06-05, completion estimated 2025-12: https://clinicaltrials.gov/study/NCT06393452?term=pp405&rank=1 https://clinicaltrials.gov/study/NCT06393452?term=pp405&rank...
• kettleballroll 2y ago
  Yes. The tldr is that this is a drug that showed promise that is in the early pretrial stages. Most drugs fail before they reach the market. Even if this one doesn't, it will take a decade at least before this will be available.